HEMOSTEMIX INC (HEM.CA) Stock Income Statement
TSX-V:HEM - TSX Venture Exchange - CA4236943060 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 2.69M | 1.98M | 2.16M | 4.58M | 6.66M | |||
| Research and Development | 0.00 | 3.00K | 384.90K | 622.70K | 179.90K | |||
| Selling, General, and Administrative Expenses | 2.69M | 1.98M | 1.77M | 3.95M | 6.47M | |||
| Operating Income | -2.69M | -1.98M | -2.16M | -4.58M | -6.66M | |||
| Interest Income/Expense | -737.20K | -637.70K | -539.90K | -172.80K | 41.30K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 73.10K | |||
| Non Recurring Items | N/A | 0.00 | 194.80K | 2.20K | 0.00 | |||
| Income Before Taxes | -3.43M | -2.62M | -2.50M | -4.75M | -6.54M | |||
| Income Tax | N/A | N/A | 0.00 | 486.90K | -255.80K | |||
| Net Income | -3.43M | -2.62M | -2.50M | -5.24M | -6.29M | |||
| EBITDA | N/A | -1.98M | -2.16M | -4.58M | -6.65M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.03 | -0.07 | -0.11 | |||
| Statistics | ||||||||
All data in CAD